Diatherix And Vanderbilt University Medical Center Establish Multi-Year Clinical Study Agreement
HUNTSVILLE, Ala., Dec. 3, 2015 /PRNewswire/ -- Diatherix Laboratories, LLC, a leading provider of multiplex diagnostic services and solutions, announced today that it has established a multi-year research agreement with Vanderbilt University Medical Center and the Vanderbilt Vaccine Research Program. Diatherix will provide clinical laboratory services using its proprietary multiplex molecular diagnostic platform for the detection of infectious diseases.
Diatherix and the Vanderbilt Vaccine Research Program will collaborate on high-impact research programs that will enhance and expand both organizations' capabilities related to the detection of bacterial and viral infections in both pediatric and adult patient populations. This alliance is designed to advance scientific and medical knowledge, with a due regard for patient safety and improvement of patient outcomes, particularly in children.
"We are excited to see how multiplex molecular diagnostic tools developed at Diatherix can be evaluated for potential integration into a therapeutic program in partnership with Vanderbilt University Medical Center. Together, we see this as an opportunity to work together on the same goal to improve the lives of patients," said Dennis Grimaud, CEO of Diatherix Laboratories.
"In the current climate of complex infections and antimicrobial resistance, securing a microbiologic diagnosis as quickly as possible is an important aspect of patient care," said VUMC Principal Investigator, C. Buddy Creech, MD, MPH. "We are excited about the prospect of improving our ability to make rapid diagnoses in some of our most challenging patients, such as children with bone and joint infections, as well as those with infections of the central nervous system."
Diatherix Laboratories, LLC, is located in the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. Diatherix operates as an independent, high complexity, CAP-accredited clinical laboratory providing advanced multiplex molecular diagnostic services to assist healthcare providers in the simultaneous detection of bacteria, viruses, parasites and Candida related to infectious diseases providing one-day results and single-sample collection. For more information, please visit the company's website at www.diatherix.com.
About Vanderbilt University
Vanderbilt University Medical Center (VUMC) is composed of Vanderbilt University Hospital, Vanderbilt Psychiatric Hospital, Vanderbilt Stallworth Rehabilitation Hospital, The Vanderbilt Clinic and Medical Group, and the Monroe Carell Jr. Children's Hospital at Vanderbilt. VUMC has built a strong reputation as a leader in medical education, research and patient care throughout the Southeast and the nation over the course of its 140-year history. For more information about Vanderbilt University Medical Center, see www.mc.vanderbilt.edu.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diatherix-laboratories-and-vanderbilt-university-medical-center-establish-multi-year-clinical-study-agreement-300187691.html
SOURCE Diatherix Laboratories